TG Therapeutics, Inc.TGTXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank79
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-24.77M
↑ 79% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-120.01M
Historical baseline
PeriodValueYoY Change
2025$-24.77M+38.9%
2024$-40.52M-29.0%
2023$-31.41M+82.2%
2022$-176.17M+40.4%
2021$-295.63M-37.8%
2020$-214.51M-61.5%
2019$-132.81M-3.0%
2018$-128.93M-37.5%
2017$-93.76M-52.2%
2016$-61.59M-